SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

simbrinza 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

BRIMONIDINE TARTRATE solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution/ drops

regimed medical - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine 2.0 mg in 1 ml - brimonidine tartrate ophthalmic solution is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the iop lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

BRIMOGAN (Brimonidine Tartrate Ophthalmic Solution (0.15%) 1.5mgml) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

brimogan (brimonidine tartrate ophthalmic solution (0.15%) 1.5mgml)

arms pharma sdn. bhd. - brimonidine tartrate -

Combigan 2 mg/ml + 5 mg/ml eye drops, solution Ireland - English - HPRA (Health Products Regulatory Authority)

combigan 2 mg/ml + 5 mg/ml eye drops, solution

abbvie limited - brimonidine tartrate; timolol maleate - eye drops, solution - beta blocking agents1); timolol, combinations

BRIMONIDINE TARTRATE- brimonidine tartrate solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate- brimonidine tartrate solution/ drops

stat rx usa llc - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the lop lowering efficacy of brimonidine tartrate ophthalmic solution 0.2% diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution 0.2% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

BRIMONIDINE TARTRATE - brimonidine tartrate solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate - brimonidine tartrate solution/ drops

osmotica pharmaceutical corp. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the iop lowering efficacy of brimonidine tartrate ophthalmic solution, 0.2% diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution, 0.2% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

ENIDIN brimonidine tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

enidin brimonidine tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: polyvinyl alcohol; benzalkonium chloride; citric acid; hydrochloric acid; sodium citrate dihydrate; sodium chloride; sodium hydroxide; purified water - indications:enidin eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: enidin eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension.enidin eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tube Australia - English - Department of Health (Therapeutic Goods Administration)

mirvaso brimonidine 3.3 mg/g (as tartrate) gel tube

galderma australia pty ltd - brimonidine tartrate, quantity: 5 mg/g (equivalent: brimonidine, qty 3.3 mg/g) - gel - excipient ingredients: carbomer 974p; methyl hydroxybenzoate; phenoxyethanol; glycerol; titanium dioxide; propylene glycol; sodium hydroxide; purified water - mirvaso is indicated for the treatment of facial erythema of rosacea in adult patients

Brimonidine 0.2% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brimonidine 0.2% eye drops

alliance healthcare (distribution) ltd - brimonidine tartrate - eye drops - 2mg/1ml

Brimonidine 0.2% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brimonidine 0.2% eye drops

a a h pharmaceuticals ltd - brimonidine tartrate - eye drops - 2mg/1ml